Bridge vs. standard Part D: the cost comparison
Short answer: You don't get to choose — your diagnosis picks your path (diabetes, moderate-to-severe sleep apnea, and MASH route to Part D; weight-loss-only routes to the Bridge). But knowing the differences matters: the Bridge is predictable ($50 flat, no deductible), while Part D is variable but cap-protected, Extra-Help-eligible, and often cheaper across a full year of heavy drug use.
Program facts last verified against CMS: July 21, 2026
The structural differences at a glance
The Bridge: $50 every month, no deductible, no cap accumulation, no Extra Help, identical in every state and plan. Standard Part D: your plan's tier copay (which may exceed or undercut $50), possibly a deductible early in the year, full TrOOP accumulation toward the ~$2,100 cap, Extra Help applies, and details vary plan to plan.
The crossover logic: someone taking several expensive medications reaches the Part D cap and then pays $0 for covered drugs — so a Part D-covered GLP-1 can cost less than $600/year in total. Someone with few other drug costs may never reach the cap, making the Bridge's flat $50 the better deal. And for anyone with Extra Help, the Part D path is almost always cheaper.
Where you have real leverage
On the Part D path, plans differ meaningfully in GLP-1 tiers and restrictions — comparing formularies during Open Enrollment (October 15 – December 7) is where the money is. On the Bridge path, the only lever is time: starting sooner means more months at $50 before the program's December 2027 end.
Take the 2-minute eligibility check →
Common questions
Can I pick whichever path is cheaper for me?
No — the routing follows your diagnoses. Type 2 diabetes, moderate-to-severe OSA, and MASH mean Part D; otherwise, weight-loss use goes through the Bridge.
Could I be on both paths at once?
The programs are designed to route each person one way. If your health situation genuinely spans both (say, you develop diabetes mid-treatment), talk to your prescriber about how your coverage transitions — and see our guide to switching paths.
Which path do most people end up on?
Numerically, far more Medicare beneficiaries take GLP-1s for diabetes under Part D than qualify for the Bridge. The Bridge's ~3.8 million eligible population is specifically the weight-loss-without-routing-conditions group.
Related
Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF